192 related articles for article (PubMed ID: 7532038)
1. Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors.
Agarwal R; Doren S; Hicks B; Dunbar CE
Blood; 1995 Mar; 85(5):1306-12. PubMed ID: 7532038
[TBL] [Abstract][Full Text] [Related]
2. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.
Moore S; Haylock DN; Lévesque JP; McDiarmid LA; Samels LM; To LB; Simmons PJ; Hughes TP
Blood; 1998 Oct; 92(7):2461-70. PubMed ID: 9746786
[TBL] [Abstract][Full Text] [Related]
3. Stem cell factor and chronic myeloid leukemia CD34+ cells.
Moore S; McDiarmid LA; Hughes TP
Leuk Lymphoma; 2000 Jul; 38(3-4):211-20. PubMed ID: 10830729
[TBL] [Abstract][Full Text] [Related]
4. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
[TBL] [Abstract][Full Text] [Related]
5. KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors.
Corbin AS; O'Hare T; Gu Z; Kraft IL; Eiring AM; Khorashad JS; Pomicter AD; Zhang TY; Eide CA; Manley PW; Cortes JE; Druker BJ; Deininger MW
Cancer Res; 2013 Sep; 73(18):5775-86. PubMed ID: 23887971
[TBL] [Abstract][Full Text] [Related]
6. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
[TBL] [Abstract][Full Text] [Related]
7. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
Cervantes F; Pierson BA; McGlave PB; Verfaillie CM; Miller JS
Blood; 1996 Mar; 87(6):2476-85. PubMed ID: 8630414
[TBL] [Abstract][Full Text] [Related]
8. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?
Verfaillie CM; Hurley R; Lundell BI; Zhao C; Bhatia R
Acta Haematol; 1997; 97(1-2):40-52. PubMed ID: 8980609
[TBL] [Abstract][Full Text] [Related]
9. Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor.
Issaad C; Vainchenker W
Blood; 1994 Nov; 84(10):3447-56. PubMed ID: 7524739
[TBL] [Abstract][Full Text] [Related]
10. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
11. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM
Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor is involved in the supportive effect by bone marrow--derived stromal cells of the factor-dependent human cell line UT-7.
Auffray I; Chevalier S; Froger J; Izac B; Vainchenker W; Gascan H; Coulombel L
Blood; 1996 Sep; 88(5):1608-18. PubMed ID: 8781416
[TBL] [Abstract][Full Text] [Related]
13. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
[TBL] [Abstract][Full Text] [Related]
14. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
15. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
[TBL] [Abstract][Full Text] [Related]
16. Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow.
Fogli M; Amabile M; Martinelli G; Fortuna A; Rondelli D; Ratta M; Curti A; Tura S; Lemoli RM
Br J Haematol; 1998 Apr; 101(1):119-29. PubMed ID: 9576192
[TBL] [Abstract][Full Text] [Related]
17. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
Gore SD; Amin S; Weng LJ; Civin CI
Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
[TBL] [Abstract][Full Text] [Related]
18. Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.
Liesveld JL; Broudy VC; Harbol AW; Abboud CN
Exp Hematol; 1995 Mar; 23(3):202-9. PubMed ID: 7533098
[TBL] [Abstract][Full Text] [Related]
19. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
20. Blast colony-forming cell binding from CML bone marrow, or blood, on stromal layers pretreated with G-CSF or SCF.
Gidáli J; László E; Halm G; Fehér I
Cell Prolif; 2002 Feb; 35(1):1-7. PubMed ID: 11856174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]